Western Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Western Wealth Management's FBT Position: Q1 2026 in Review
Western Wealth Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.49% in Q1 2026, buying an estimated $4.76K and bringing the position to 4,762 shares worth $956K. The position accounts for 0.04% of the portfolio, ranked #459.
Western Wealth Management first reported a position in FBT in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.21M in Q3 2023. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Western Wealth Management held 4,762 shares of First Trust NYSE Arca Biotechnology Index Fund worth $956K as of Q1 2026.
- Western Wealth Management bought 23 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $4.76K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of Western Wealth Management's portfolio in Q1 2026, its #459 holding.
- Western Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 23 quarters since.
- Western Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.21M in Q3 2023.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.